Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00270959 · ClinicalTrials.gov registry record · Phase 1
Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 207
- Enrollment target
NCT00270959: Completed Phase 1 study, sponsored by University of Washington.
NCT00270959 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 207 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (245% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00270959, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 207 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of patient-centered collaborative care that combines behavioral therapy and drug therapy as compared to usual care in reducing symptoms of post-traumatic stress disorder in people who have survived a traumatic injury.
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Standard Care Control
- DRUG FDA-Approved Anti-Anxiety Medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2006-06 |
| Est. Completion | 2013-03 |
| Phase | Phase 1 |
What the finished NCT00270959 record still lists
NCT00270959 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (245% higher).
The record links to 0 conditions, and to 4 interventions - of which Motivational Interviewing is the first listed.
NCT00270959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00270959 about?
NCT00270959 is a clinical study titled "Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury". This study will evaluate the effectiveness of patient-centered collaborative care that combines behavioral therapy and drug therapy as compared to usual care in reducing symptoms of post-traumatic stress disorder in people who have survived a traumatic injury.
What is the current status of trial NCT00270959?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 207 participants. The study started on 2006-06. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00270959?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Cognitive Behavioral Therapy (BEHAVIORAL), Standard Care Control (BEHAVIORAL), FDA-Approved Anti-Anxiety Medications (DRUG).
Who is sponsoring clinical trial NCT00270959?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00270959's enrollment target sits among peer trials
207 252nd of 2000 higher than 1,748 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia